Results 141 to 150 of about 88,572 (244)

ANCA-positive and ANCA-negative granulomatosis with polyangiitis [PDF]

Clinical pharmacology and therapy, 2020
I.G. Smirnova, N.M. Bulanov, A.S. Zykova, E.A. Makarov, P.I. Novikov, S.V. Moiseev   +5 more
openaire   +1 more source

Effectiveness of plasmapheresis in ANCA clearance in patients with ANCA-associated vasculitides.

Przeglad lekarski, 2016
Plasmapheresis is a therapeutic method based on removal of high molecular weight particles from blood. It is used in a variety of clinical entities in which pathogenic role of such particles has been proven e.g. ANCA-associated vasculitides (granulomatosis with polyangiitis [GPA] and microscopic polyangiitis [MPA]).
Górka, Jacek, Polok, Kamil, Nowak, Ilona, Włudarczyk, Anna, Sydor, Wojciech, Padjas, Agnieszka, Sznajd, Jan, Szczeklik, Wojciech, Musiał, Jacek   +8 more
openaire   +2 more sources

两种方法联合检测风湿性疾病中ANCA的临床意义

Zhongguo shiyan zhenduanxue, 2008
目的评价间接免疫荧光法（IIF）和酶联免疫吸附试脸（ELISA）检测抗中性粒细胞胞浆抗体（ANCA）的临床意义。方法采用IIF和ELISA方法联合对120例风湿性疾病患者的血清进行ANCA检测。结果在120例检验标本中C-ANCA阳性与PR3-ANCA阳性是一一对应的;而在37例SLE患者中,有7例P-ANCA阳性,1例a-ANCA阳性,1例C-ANCA阳性,MPO-ANCA阳性者6例,PR3-ANCA阳性者1例;在31例RA中4例P-ANCA阳性,而5例MPO-ANCA阳性 ...
李贵玲, 郑岚, 谢风, 周劲松, 李威, 刘鹏, 宋丽娜, 何成彦   +7 more
doaj  

FP242ANCA-associated vasculitis with both MPO-ANCA and PR3-ANCA shares characteristics of ANCA-associated vasculitis with single ANCA [PDF]

Nephrology Dialysis Transplantation, 2019
Yumi Yang, Sun Moon Kim, Jinhyun Kim
openaire   +1 more source

ANCAs away

Gut, 1999
openaire   +3 more sources

Pathophysiology of ANCA-associated vasculitis: are ANCA really pathogenic? A note of caution - Reply:are ANCA really pathogenic?

, 2003
The strong relation between antineutrophil cytoplasmic autoantibodies (ANCA) and primary vasculitic syndromes suggests a pathophysiological role for ANCA.Experimental evidence for the pathogenic potential of ANCA has been derived from in vitro studies ...
Heeringa, P; id_orcid, Tervaert, JWC
core  

Beyond the CE Mark: A Call to Action for Minimum CGM Accuracy Standards in Central and Eastern European Nations

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9747-9752, November 2026.
Tomasz Klupa, Silvija Canecki‐Varžić, Adriana Ilavská, Andrej Janez, Sanja Klobučar, Mladen Krnić, Tatjana Milenkovic, Peter Novodvorský, Martin Prázný, Marko Simunovic, Jan Šoupal, Anca Pantea Stoian, Agnieszka Szadkowska, Tsvetelina Tankova, Tadej Battelino   +14 more
wiley   +1 more source

Inflammatory regulatory mechanisms and targeted therapy of antineutrophil cytoplasmic antibodies in atherosclerosis (Review). [PDF]

Int J Mol Med
Cui J, Cui Q, Dou J, Li X, Chang W, Shi L, An L.   +6 more
europepmc   +1 more source

Evaluation of ANCA in vasculitis and non-vasculitis diseases

Purpose: The present study aims to evaluate the existence of anti-neutrophil cytoplasmic antibody (ANCA) in vasculitis and non-vasculitis diseases.
Kaleli, İ., Özkan, B., Mete, E., Ergin, Ç., Demir, M., Çalışkan, A., Öner, S.Z.   +6 more
core   +1 more source

ANCA—pathophysiology revisited [PDF]

Clinical and Experimental Immunology, 1995
C G, Kallenberg, E, Brouwer, A H, Mulder, C A, Stegeman, J J, Weening, J W, Tervaert   +5 more
openaire   +2 more sources